Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Madrigal Pharmaceuticals Q2 EPS $(3.72) Down From $(3.18) YoY

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.72) per share. This is a 16.98 percent decrease over losses of $(3.18) per share from the same period last year.
byBenzinga Newsdesk
August 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Madrigal Pharmaceuticals (NASDAQ:MDGL) reported quarterly losses of $(3.72) per share. This is a 16.98 percent decrease over losses of $(3.18) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts